Resistin is implicated in cardiovascular, metabolic, and autoimmune diseases, as it affects molecular pathways associated with inflammation, including the activation of NFKB1 nuclear factor kappa B (NF-kB) by Toll-like receptor 4 (TLR4). This evidence concerns the gene TLR4 and autoimmune disease.